Kilitch Drugs (India) consolidated net profit rises 81.86% in the September 2024 quarter

Net profit of Kilitch Drugs (India) rose 81.86% to Rs 8.62 crore in the quarter ended September 2024 as against Rs 4.74 crore during the previous quarter ended September 2023. Sales rose 15.22% to Rs 47.47 crore in the quarter ended September 2024 as against Rs 41.20 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	47.47	41.20	15
OPM %	12.85	20.92	-
PBDT	10.95	7.60	44
PBT	10.35	6.78	53
NP	8.62	4.74	82